With careful analysis to mitigate risk, disposable technology and process closure can enable adaptable designs and reduced costs.
Kim L. Nelson
Advertisement
Articles by Kim L. Nelson
Advertisement
Latest Updated Articles
Approaches for Flexible Manufacturing Facilities in Vaccine ProductionPublished: November 2nd 2011 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
